Results

1–5 of 5 results for Neovascular age related macular degeneration

Indirect Comparison of the Relative Effectiveness of Faricimab vs Aflibercept 8 mg in DME and nAMD
Nikolas JS London, MD, FACS, FASRS
Annual Meeting Talks
2025
Safety Profiles of Combined Anticomplement and Anti-VEGF Intravitreal Therapies for Age-Related MacularDegeneration From Real-World Data
Edward H. Wood, MD, FASRS
Annual Meeting Talks
2025
Baseline Characteristics Associated With Catastrophic Vision Loss Due to Subretinal Hemorrhage in Patients Undergoing Treatment for Neovascular Macular Degeneration
Eric W Schneider, MD
Annual Meeting Talks
2024
Analysis of the Long-term Visual Outcomes of ForeseeHome Remote Telemonitoring.
Michael J. Elman, MD
Annual Meeting Talks
2022
Nonneovascular Age Related Macular Degeneration and Fluid
David Sarraf, MD
Annual Meeting Talks
2020